HbA1c FIA Test CE | CTK-F6100

The glycosylated Hemoglobin A1c (HbA1c) Fluorescence ImmunoAssay (FIA) Test is a lateral flow chromatographic fluorescence immunoassay for the quantitative detection of HbA1c in human whole blood using the RaFIA system. This test is intended for in vitro diagnostic use only.

HbA1c is the product of hemoglobin combining with blood glucose in red blood cells, providing an average blood glucose level of the past 3 months. HbA1c is a clinically useful index of mean glycemia for long-term blood glucose control. HbA1c is considered as a more reliable marker in monitoring glycemia over the reading of a conventional glucometer. The high sensitivity and specificity of HbA1c rapid quantitative test is achieved by sandwich fluorescence immunoassay technology.

The HbA1c FIA Test was developed to detect circulating HbA1c in whole blood within 5 minutes, without the use of cumbersome laboratory equipment, and requiring minimally trained laboratory personnel.